Carcinogenesis and Chemotherapy Flashcards

1
Q

Differentiate between ‘oncogenes’ and ‘tumor suppressor’ genes

A

Oncogenes generally function normally to promote cell growth and survival (gas pedal on car). Mutations to oncogenes (which tend to be dominant-acting) prevent modulation and regulation of these genes (gas can’t be lifted), leaving them constitutively active.

TS Genes (like p53) are like brakes or check-points for a car. They are recessive-acting, so inactivation requires mutations to both alleles (often one is inherited, the other is acquired–loss of heterogeneisity).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List 5 important genotoxic carcinogens:

A
  1. polycyclic aromatic hydrocarbons (PAHs)
  2. Mycotoxins
  3. Radiation
  4. Asbestos
  5. Heavy metals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe how Benzene can cause cancer:

A

Exposure is occupational or through tobacco smoking. Benzene is activated to toxic metabolites via a p450 dependent mechanism. Converted to 1,4 benzoquinone by myeloperoxidase in bone marrow.

Susceptibility depends on individual’s p450 genetic variant.
Toxic to bone marrow, blood. Causes leukemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do non-genotoxic carcinogens cause cancer?

A

**They do not interact with DNA, but instead impact cellular growth, increase DNA synthesis (mitosis), inhibit repair functions, alter chromatin modifications, alter cell signalling pathways, and induce inflammation.

They are effective at high concentrations and over chronic exposures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Differentiate between ‘initiation’ and ‘promotion’ as they pertain to carcinogenesis:

A

Initiation is a mutagenic event, irreversible, and occurs in one cell (clone) - could be result of a genotoxic exposure.

Promotion is non-mutagenic and reversible. Continued exposure will promote cell proliferation. This could be a non-genotoxic exposure. Promoter may also be a true DNA-bound promoter of an oncogene initiator region.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does the EPA assess environmental carcinogens?

A

Non-threshold assumption, allow for 0 exposure (no safe level, where the EU allows some safe level of exposure for non-genotoxic carcinogens).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Does the FDA require any carcinogenicity testing on new drugs?

A

Yes, require drug sponsors to submit data on carcinogenicity testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define: S-phase

A

the DNA Synthesis stage of cell replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define: G1 phase

A

A growth phase that follows mitosis in preparation for the next division (as opposed to G0- differentiation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define: G2 phase

A

follows S phase. Includes synthesis of mitotic componants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define: M-phase

A

Mitosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define: cell cycle specific

A

Drugs that inhibit or kill cells only if they are cycling at a specific stage (DNA synthesis inhibitors, mitotic inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define: cell cycle non-specific

A

Drugs that work throughout the cell cycle (alkylating agents)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Log kill hypothesis

A

Cytotoxic drugs kill a constant FRACTION of cells, rather than a specific dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How did resistance to chemotherapy come about? What is the mechanisms (5)?

A

Happens due to repetitive therapy. Mechanisms:

  1. Decreased target sensitivity
  2. Detoxifying enzymes (increased inactivation)
  3. Decreased uptake (reduced permeability or inc. efflux)
  4. Increased expression of target enzyme (requires more drug for inhibition)
  5. Increased levels of competitive substrate for enzyme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Methotrexate: indication

A

arthritis, auto-immune diseases, cancer (larger dose)

17
Q

Methotrexate: mechanism

A

Blocks the activity of dihydrofolate reductase (DHFR) and depletes cell of FH4 (tetrahydrofolate) leading to inhibition of DNA synthesis and growth.

18
Q

Methotrexate: toxicities

A

Bone marrow, GI mucosa, hepatotoxicity with long term dose.

19
Q

Methotrexate: ADME

A

Oral or parenteral preps. Absorption is better at lower doses. Renal elimination.

20
Q

Fluorouracil: mechanism

A

Analog of thymidine. Inhibits DNA synthesis (thymadylate synthase*) and RNA function. Prodrug must be metabolized to active drug.

21
Q

Fluorouracil: indication

A

Topical for actinic keratoses and non-invasive skin cancer.

22
Q

Fluorouracil: ADME

A

Administered IV or topical. Metabolized extensively. Secreted renally.

23
Q

Fluorouracil: toxicities

A

Nausea/vomiting, myelosuppression, oral, GI ulceration.

24
Q

Hydroxyurea: indication

A

Used for leukemia, radiation therapy, inducer of HgF in patients with sickle cell disease.

25
Q

Hydroxyurea: mechanism

A

Inhibits enzyme ribonucleotide reductase, which is required to convert UDP–>dUDP. Effectively stops DNA replication.

In sickle cell, suppression of erythrocyte precursors causes upregulation of promoters for HgF.

26
Q

Hydroxyurea: route

A

PO

27
Q

Hydroxyurea: toxicity

A

Leukopenia, anemia, GI disturbances, TERATOGENIC.

**Does not increase the risk of secondary leukemia in sickle cell pts.

28
Q

Cyclophosphamide: mechanism

A

Alkylating agent. Crosslinks DNA (G-G) so that replication/transcription are impaired.

29
Q

Cyclophosphamide: indication

A

Management of rheumatoid disorders, immunosuppression, autoimmune nephritis, bone marrow xplant.

30
Q

Cyclophosphamide: ADME

A

Oral or IV admin. Completely absorbed. Prodrug, metabolism is necessary for activity. Active metabolite is phosphoramide mustard. Acrolein is also produced, which is toxic.

31
Q

Cyclophosphamide: toxicity

A

Alopecia, nausea, vomiting, myelosuppression, hemorrhagic cystitis-acrolein